BioAsia 2026 International Summit In Hyderabad

BioAsia 2026 International Summit: The 23rd edition of BioAsia 2026 international summit is currently taking place at the Hyderabad international convection center(HICC) India. As the world reaches a critical inflection point where biology meets deep technology, this two-day global conference serves as the epicenter for innovations that are redefining modern medicine and focuses on leveraging advanced technology to shape the future of healthcare. 

Key Highlights of the Summit 

The BioAsia 2026 summit is hosted by the Government of Telangana, the summit has scaled significantly this year, moving to HITEX Exhibition Centre (Hall 4) to accommodate a record-breaking 4,000+ delegates and 500+ global companies. 

The summit highlights the shift from experimental technology to real-world execution. The event focuses on how artificial intelligence and intelligent manufacturing are compressing R&D timelines and making healthcare more personalized.The summit is structured to bridge the gap between laboratory breakthroughs and commercial scale which includes

• AI-Driven Discovery

• Next-Gen Biologics

• Global Capability Centres (GCCs)

• The Startup Ecosystem

LIVE: Hon’ble Chief Minister Sri A. Revanth Reddy participates in the inauguration of BioAsia 2026 at HITEX. https://t.co/B9qCeUuZ3h

— Revanth Reddy (@revanth_anumula) February 17, 2026

Distinguished Speakers of the BioAsia Summit

BioAsia 2026 features a powerhouse line up of global leaders, including Dr. Howard Y. Chang: Chief Scientific Officer, Amgen (USA) Pushmeet Kohli a Vice President of Science, Google DeepMind (UK), Madeleine Roach EVP, Head of Business Operations, Sanofi (France) Dr. Stefan Miltenyi: Founder & President, Miltenyi Biotec (Germany) and Anton Groom a Chief AI Officer, MSD (USA).

Telangana’s Vision as a Global Hub

The summit reinforces Hyderabad's position as a global life sciences powerhouse. Building on the "next-gen life sciences policy" announced in Davos. The Telangana government intends to use BioAsia to draw additional investment into Genome Valley and the state's developing digital health ecosystem with over $3 billion in planned trade and investment conversations.

The 23rd edition is a watershed point in India's emergence as a "TechBio" leader, guaranteeing that the next era of healthcare is more predictive, precise, and equal.

Also Read: India AI Impact Summit 2026:Theme, Venue and Full List of World Leaders & Tech CEOs